Patent details

EP1771471 Title: GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES

Basic Information

Publication number:
EP1771471
PCT Application Number:
PCT/US/2005/024229
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057892895
PCT Publication Number:
WO/2006/023148
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
French Title of Invention:
LIGNEES DE CELLULES TUEUSES, NATURELLES, HUMAINES ET GENETIQUEMENT MODIFIEES
German Title of Invention:
GENETISCH MODIFIZIERTE, MENSCHLICHE, NATÜRLICHE KILLERZELLENLINIEN:
SPC Number:

Dates

Filing date:
08/07/2005
Grant date:
16/09/2009
EP Publication Date:
16/09/2009
PCT Publication Date:
02/03/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/04/2007
EP B1 Publication Date:
16/09/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/07/2010
Expiration date:
08/07/2025
Renunciation date:
Revocation date:
28/04/2017
Annulment date:

Owner

From:
08/07/2005
 
 

Name:
FOX CHASE CANCER CENTER
Address:
333 Cottman Avenue, Philadelphia, PA 19111-2497, United States (US)

Inventor

Name:
CAMPBELL Kerry, S.
Address:
United States (US)

Priority

Priority Number:
586581 P
Priority Date:
10/07/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/705;

Publication

European Patent Bulletin

Issue number:
201725
Publication date:
21/06/2017
Description:
Revocation of the European patent
Filing date Document type Number of pages